Healthcare Integrity & Anti-Fraud Enforcement

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

October 13, 2025

Primary Completion Date

October 13, 2034

Study Completion Date

October 13, 2034

Conditions
Healthcare Fraud SchemesKickback NetworksSupply Chain VulnerabilitiesGovernance FailuresWhistleblower ActivationRegulatory Escalation PathwaysValidator Oversight & DAO GovernancePublic Transparency & Auditability
Interventions
OTHER

Validator-Governed Reform & Regulatory Escalation Protocol

This intervention deploys a validator-governed framework to monitor, escalate, and reform healthcare facilities exhibiting fraud, kickback schemes, and supply chain vulnerabilities. It integrates notarized affidavits, smart contract enforcement, NFT fiscal declarations, and DAO voting logic to trigger sanctions, regulatory complaints, and operational restructuring. Facilities are observed prospectively, with all actions logged to a public dashboard and anchored via SHA-256 hash notarization. No biospecimens are retained; all data is legal, technical, and governance-based.

DEVICE

Coalition-Grade Validator Dashboard Module (CVDM-1)

The Coalition-Grade Validator Dashboard Module (CVDM-1) is a secure, web-based device deployed across enrolled healthcare facilities to enable real-time validator oversight, whistleblower affidavit intake, and smart contract enforcement. It integrates QR-linked audit trails, NFT fiscal declarations, and DAO voting logic. The device anchors all inputs via SHA-256 hash notarization and transmits reform metrics to coalition dashboards. CVDM-1 supports public transparency, regulatory escalation, and validator governance across the PHX-AFK-US Protocol. It does not collect biospecimens and operates solely within legal, technical, and governance domains.

DRUG

Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1)

The Coalition-Flagged Pharmaceutical Audit Trigger (CFPAT-1) is a governance-based drug intervention targeting facilities with suspected fraud, kickback schemes, or supply chain irregularities involving pharmaceuticals. While not a therapeutic agent, CFPAT-1 functions as a regulatory scaffold that flags drug procurement, formulary manipulation, and referral-linked prescribing patterns. It integrates validator ballots, smart contract logic, and SHA-256 hash anchors to escalate complaints to CMS, DOJ, and state boards. All flagged drugs are traced via QR-linked audit trails and NFT fiscal declarations. No biospecimens are retained; the intervention operates within legal, technical, and governance domains.

Trial Locations (1)

10016

Truway Health, Inc. , View 34, 401 E 34th Street, S11P, New York, NY 10016, New York

All Listed Sponsors
lead

Truway Health, Inc.

INDUSTRY

NCT07217730 - Healthcare Integrity & Anti-Fraud Enforcement | Biotech Hunter | Biotech Hunter